Home > PB Ratio > GLAND PHARMA

GLAND PHARMA
PB (Price/Book ) Ratio

The Current P/B Ratio of GLAND PHARMA is 3.64.

Share Price ₹2,287.9Jun 09,2026
Market Cap ₹37,750.4 Cr
Book Value₹10,358.0 CrMar2026 - Consolidated Results
Price/Book 3.64xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of GLAND PHARMA

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of GLAND PHARMA is calculated as :

Current Market Cap [ ₹37,750.4 Cr] as on Jun 09,2026

(/) Book Value [ ₹10,358.0 Cr] based on Mar2026 - Consolidated Results

(=) P/B Ratio [ 3.64x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for GLAND PHARMA , the investors are currently willing to pay '3.64 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GLAND PHARMA !

The chart below summarizes the trend in P/B Ratio of GLAND PHARMA over the last five years.

Historical PB (Price/Book ) ratio chart of GLAND PHARMA


PB Ratio Performance Analysis for GLAND PHARMA

- GLAND PHARMA 's latest p/b ratio is 3.64x.

- GLAND PHARMA 's p/b ratio for fiscal years ending Mar2025 to Mar2021 averaged 4.68x.

- GLAND PHARMA 's operated at median p/b ratio of 3.48x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GLAND PHARMA 's p/b ratio peaked in Mar2022 at 7.52x.

- GLAND PHARMA 's p/b ratio hit its five-year low in Mar2023 of 2.63x.


How does GLAND PHARMA 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
GLAND PHARMA 10,358.003.6437,750.4
SUN PHARMACEUTICAL INDUSTRIES LTD83,570.105.11426,938.0
DIVIS LABORATORIES LTD16,761.0010.70179,361.0
TORRENT PHARMACEUTICALS LTD8,388.4318.05151,385.0
CIPLA LTD34,369.403.24111,220.0
DR REDDYS LABORATORIES LTD37,891.502.79105,899.0
MANKIND PHARMA LTD16,300.306.0698,745.3
LUPIN LTD22,448.304.61103,490.0
ZYDUS LIFESCIENCES LTD27,111.404.10111,264.0
AUROBINDO PHARMA LTD37,891.002.2083,208.3
LAURUS LABS LTD5,275.0814.5976,955.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs GLAND PHARMA 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.20x
Max industry PB 18.05x
Median industry PB 4.61x
Average industry PB 6.83x



You may also like the below Video Courses